Detalhe da pesquisa
1.
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805.
Prostate
; 82(12): 1176-1185, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538398
2.
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study.
Invest New Drugs
; 39(5): 1298-1305, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738668
3.
Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate.
Dermatol Online J
; 26(6)2020 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32815695
4.
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
Cancer
; 125(4): 533-540, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570744
5.
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.
Oncologist
; 24(11): 1497-1501, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399500
6.
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(12): 1529-1554, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805523
7.
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
Br J Cancer
; 118(11): 1434-1441, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765151
8.
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
N Engl J Med
; 373(8): 737-46, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26244877
9.
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Lancet Oncol
; 17(3): 378-388, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26794930
10.
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Support Care Cancer
; 24(7): 2837-42, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26838019
11.
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma.
HPB (Oxford)
; 17(7): 587-93, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800066
12.
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
Clin Cancer Res
; 30(1): 63-73, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861407
13.
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
J Clin Oncol
; 42(10): 1114-1123, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261983
14.
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.
Breast Cancer Res Treat
; 137(2): 483-92, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23242585
15.
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma.
Invest New Drugs
; 31(3): 707-13, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22864469
16.
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
J Clin Oncol
; 41(4): 715-723, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706735
17.
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.
Eur Urol Oncol
; 2023 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105142
18.
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.
Cancer
; 118(9): 2424-30, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953248
19.
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.
Cancer
; 118(17): 4139-47, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22180287
20.
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Oncologist
; 17(1): 13, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22210086